A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment
Trial Number
NCT01979393 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Uterine Sarcoma
Lead Cooperative Group
Participating Groups
GOG-F
SGCTG